BNP Paribas Financial Markets Has $1.51 Million Position in Azenta, Inc. (NASDAQ:AZTA)

BNP Paribas Financial Markets lifted its position in Azenta, Inc. (NASDAQ:AZTA) by 285.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,227 shares of the company’s stock after buying an additional 23,132 shares during the quarter. BNP Paribas Financial Markets owned about 0.06% of Azenta worth $1,513,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AZTA. Cerity Partners LLC increased its stake in shares of Azenta by 21.2% in the third quarter. Cerity Partners LLC now owns 39,031 shares of the company’s stock worth $1,891,000 after purchasing an additional 6,840 shares during the period. Commerce Bank lifted its holdings in shares of Azenta by 42.8% during the third quarter. Commerce Bank now owns 18,097 shares of the company’s stock worth $877,000 after buying an additional 5,428 shares during the last quarter. Premier Fund Managers Ltd bought a new stake in shares of Azenta in the third quarter valued at approximately $686,000. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Azenta during the third quarter worth $1,979,000. Finally, Quest Partners LLC grew its position in Azenta by 31.5% in the 3rd quarter. Quest Partners LLC now owns 7,941 shares of the company’s stock worth $385,000 after purchasing an additional 1,902 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Insider Activity

In other Azenta news, Director William L. Cornog bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were acquired at an average cost of $39.60 per share, with a total value of $495,000.00. Following the acquisition, the director now owns 14,755 shares of the company’s stock, valued at $584,298. The trade was a 554.32 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO John Marotta bought 12,717 shares of the stock in a transaction dated Monday, November 18th. The shares were purchased at an average price of $39.48 per share, for a total transaction of $502,067.16. Following the purchase, the chief executive officer now owns 99,612 shares of the company’s stock, valued at $3,932,681.76. This trade represents a 14.63 % increase in their position. The disclosure for this purchase can be found here. Insiders have sold 3,018 shares of company stock worth $126,689 over the last ninety days. Insiders own 1.77% of the company’s stock.

Azenta Price Performance

Azenta stock opened at $45.59 on Monday. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of -15.35 and a beta of 1.49. The company’s 50 day simple moving average is $44.72 and its 200 day simple moving average is $49.69. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.08. The company had revenue of $170.00 million for the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period last year, the firm posted $0.13 earnings per share. As a group, analysts predict that Azenta, Inc. will post 0.41 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently weighed in on AZTA. Needham & Company LLC lowered their price objective on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Evercore ISI reduced their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $63.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.